Evidence map›Paper›PMID 39042359›Full record

ArticleJournal of fluorescence2025

Development of a Pyrone-Fused Tricyclic Scaffold-based Ratiometric Fluorescent Probe for Al

Fumiko Hara, Naoko Mizuyama, Takeshi Fujino, Shinya Takada, Takashi Temma, Hideo Saji, Takahiro Mukai, Masayori Hagimori

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fumiko HaraLaboratory of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien Kyubancho, Nishinomiya, 663-8179, Japan.ORCID http://orcid.org/0000-0003-3025-6720
Naoko MizuyamaDivision of Medical Innovation, Translational Research Center for Medical Innovation, 1-5-4 Minatojima-Minamimachi, Chuo-Ku, Kobe, 650-0047, Japan.
Takeshi FujinoDepartment of Environmental Science and Technology, Graduate School of Science and Engineering, Saitama University, 255 Shimo-Okubo, Sakura-Ku, Saitama, 338-8570, Japan.
Shinya TakadaLaboratory of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien Kyubancho, Nishinomiya, 663-8179, Japan.
Takashi TemmaDepartment of Biofunctional Analysis, Graduate School of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, 569-1094, Japan.
Hideo SajiGraduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Takahiro MukaiDepartment of Biophysical Chemistry, Kobe Pharmaceutical University, 4-19-1 Motoyamakita Machi, Higashinada-Ku, Kobe, 658-8558, Japan.
Masayori HagimoriLaboratory of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien Kyubancho, Nishinomiya, 663-8179, Japan. hagimori@mukogawa-u.ac.jp.ORCID http://orcid.org/0000-0002-2371-911X

Funding

Japan Society for the Promotion of Science 22K12472
6 · The paper itself

Abstract

Aluminum (Al

Indexed as

AluminumFluorescent DyesPyronesMolecular StructureSpectrometry, FluorescenceAluminumFluorescent DyesPyronesAluminumFluorescent probeRatiometric fluorescenceTricyclic pyrone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.